News Results for Deltex Medical Group (DEMG)

David Moorhouse, Executive Director, bought 370,000 shares in the company on the 22nd September 2020 at a price of 0.013500p. The Director now holds 829,834 shares. Story provided by...

Haemodynamic monitoring technologies maker Deltex Medical reported wider first-half losses as revenue was hurt by a pandemic-led slowdown in elective surgical procedures. For the six months to 30...

Oesophageal Doppler monitoring company Deltex Medical reported a fall in first-half revenue, but said pent-up demand should boost activity in the second half of the year. For the half-year ended...

Medical company Deltex Medical narrowed its annual losses as lower costs offset a decline in revenue. For the year ended 31 December 2019, pre-tax losses narrowed to £210K from £1.3m on-year even...

Deltex Medical said it expected to report positive annual earnings as efforts to turnaround its business continued. For the year ended 31 December 2019, revenues fell to about £4.3m from £5m...

Nigel Keen, Chairman, bought 1,821,429 shares in the company on the 17th December 2019 at a price of 1.12p. The Director now holds 64,740,491 shares. Story provided by StockMarketWire.com...

Julian Cazalet, Non Executive Director, bought 892,857 shares in the company on the 17th December 2019 at a price of 1.12p. The Director now holds 9,397,927 shares. Story provided by...

David Moorhouse, Financial Director, bought 446,429 shares in the company on the 17th December 2019 at a price of 1.12p. The Director now holds 459,834 shares. Story provided by...

Prof Sir Duncan Nichol, Director, bought 446,429 shares in the company on the 17th December 2019 at a price of 1.12p. The Director now holds 2,754,136 shares. Story provided by...

Mark Wippell, Non Executive Director, bought 892,857 shares in the company on the 17th December 2019 at a price of 1.12p. The Director now holds 2,481,831 shares. Story provided by...

Deltex Medical said it had appointed David Moorhouse as finance director with immediate effect. Moorhouse had been overseeing the finance function at DEMG on an interim basis since 7 October...

Deltex Medical said Jonathan Shaw had resigned as finance director, effective last week, and that his employment with the group would end on or before 4 Apr 2020. The company had started a...

Cardiac output monitoring group Deltex Medical posted a narrower first-half loss after it cut sales and distribution spending. Pre-tax losses for the six months through June amounted to £0.31m,...

Deltex Medical Group said it expected to report positive half-yearly adjusted earnings even as revenues slipped in the first half of the year. Total revenues for the half-year ended 30 June 2019...

Oesophageal doppler monitoring specialist Deltex Medical Group said it had generated cash in each of the five months through April. Trading continued to be in line with expectations, it added....

Nigel Keen, Chairman, bought 8,695,652 shares in the company on the 5th February 2019 at a price of 1.13p. The Director now holds 62,918,762 shares. Story provided by StockMarketWire.com...

Deltex Medical Group said Friday it expected to deliver positive earnings in 2019 following improved performance in the final quarter of last year. The company said improved fourth quarter 2018...

Deltex Medical Group reported Monday an uptick in pre-tax losses owing to a strong prior year comparator for monitor sales and a drop in probe revenues amid a 'number of one-off events'. For the...

Nigel Keen, Chairman, bought 2,000,000 shares in the company on the 24th August 2018 at a price of 0.90p. The Director now holds 54,223,410 shares. Story provided by StockMarketWire.com Director...

Nigel Keen, Chairman, bought 3,000,000 shares in the company on the 21st August 2018 at a price of 0.83p. The Director now holds 51,000,000 shares. NOTE: Price averaged over two separate...

Nigel Keen, Chairman, bought 1,000,000 shares in the company on the 22nd August 2018 at a price of 0.90p. The Director now holds 53,000,000 shares. Story provided by StockMarketWire.com Director...

Andy Mears, Chief Executive Officer, bought 2,234,222 shares in the company on the 27th July 2018 at a price of 0.89p. The Director now holds 2,781,808 shares. Story provided by...

Nigel Keen, Chairman, bought 6,000,000 shares in the company on the 26th July 2018 at a price of 0.84p. The Director now holds 48,223,410 shares. Story provided by StockMarketWire.com Director...

Deltex Medical Group said Wednesday that Ewan Phillips had resigned as Chief Executive. Phillips concluded that a change of leadership was needed to guide the group through its next stage of...

Deltex Medical said per-tax losses narrowed to £2.1m in the year to the end of December, from a loss of £2.5m the previous year supported by improved margins and lower costs. Group revenues fell...

Ewan Phillips, Chief Executive Officer, exercised 800,000 shares in the company on the 12th February 2018 at a price of 1.00p. The Director now holds 4,682,111 shares. NOTE: Dealing will actually...

Deltex Medical Group, a global leader in oesophageal Doppler monitoring, has announced the addition of a major new hospital in the USA. The group said the hospital was a university teaching...

Deltex Medical Group expects losses for the year ended 31 Dec to be higher than market forecasts. The group said US revenues rose by 5% to £2.0m but overall revenues fell to £5.9m from £6.3m with...

Deltex Medical has announced the launch this week of its revolutionary concept in advanced haemodynamic monitoring, the TrueVue system. The group said the TrueVue system comprised three distinct...

Deltex Medical Group - a global leader in Oesophageal Doppler Monitoring - has announced the addition of a significant new hospital account in the US. It said the 600 bed teaching hospital...

Deltex Medical Group's revenue rose by 7% to £2.9m in the six months to the end of June and gross margins increased to 76% - up from 64% last time. Operating cash costs were reduced by £0.3m to...

Story provided by StockMarketWire.com

Deltex Medical Group said improved trends seen in the second half of 2016 continued into the first half of this year and had driven a return to growth in revenues. The group saw overall revenue...

Story provided by StockMarketWire.com

Deltex Medical Group has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 1:37pm: (LON:DEMG) Deltex Medical Group PLC share price was 0p at...

Deltex Medical Group is making good progress with sales up on a year ago on improved margins and lower operating costs, shareholders at today's annual general meeting will be told. The group has...

Story provided by StockMarketWire.com

Deltex Medical Group, a global leader in oesophageal Doppler monitoring, has been granted a new patent. Deltex Medical has been granted patent coverage for its innovative combined blood flow and...

Story provided by StockMarketWire.com

Deltex Medical Group - a global leader in oesophageal doppler monitoring - has launched its first ODM system designed specifically for veterinary use. It said this had generated £15,000 on...

Story provided by StockMarketWire.com

Story provided by StockMarketWire.com

Deltex Medical Group has confirmed that the Company will be announcing its results for the year ended 31 December 2016 on Thursday 27 April 2017, rather than 24 April as previously indicated. The...

Nigel Keen, Chairman, bought 4,137,931 shares in the company on the 22nd March 2017 at a price of 3.63p. The Director now holds 26,193,780 shares. NOTE: Subscription Story provided by...

Julian Cazalet, Non Executive Director, bought 606,897 shares in the company on the 22nd March 2017 at a price of 3.63p. The Director now holds 7,063,020 shares. NOTE: Subscription Story provided...

Chris Jones, Non Executive Director, bought 275,862 shares in the company on the 22nd March 2017 at a price of 3.63p. The Director now holds 525,862 shares. NOTE: Subscription Story provided by...

Ewan Phillips, Chief Executive Officer, bought 275,862 shares in the company on the 22nd March 2017 at a price of 3.63p. The Director now holds 2,921,051 shares. NOTE: Subscription Story provided...

Jonathan Shaw, Financial Director, bought 137,931 shares in the company on the 22nd March 2017 at a price of 3.63p. The Director now holds 262,931 shares. NOTE: Subscription Story provided by...

Deltex Medical Group has received confirmation of monitor orders worth over £0.2m which, as indicated in the trading update announced on 18 January, had moved into 2017 due to the rescheduling of...

Story provided by StockMarketWire.com

Story provided by StockMarketWire.com

Story provided by StockMarketWire.com

Deltex Medical Group has announced its most substantial account win in a UK NHS hospital for more than two years. A 450 bed NHS hospital in the South-East of England has acquired six...

Deltex Medical narrowed operating losses in the first half and announce that it has added three additional accounts to its platform programme in the US. The group said US probe revenues rose by...

Story provided by StockMarketWire.com

Deltex Medical Group says results from the first randomised controlled trial to compare post-operative outcomes when using ODM to the most commonly used alternative technology show significantly...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, expects first half group sales in statutory reporting format to be flat at approximately £2.7m (2015: £2.7m). The group...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has added two additional accounts to its platform programme in the US. The first account, the sixth platform account...

Story provided by StockMarketWire.com

Deltex Medical Group has announced the initial results of the largest ever randomised clinical trial of oesophageal Doppler monitoring which show substantial reductions in post-operative...

Story provided by StockMarketWire.com

Nigel Keen, Chairman, received in lieu of fees/salary 833,325 shares in the company on the 12th May 2016 at a price of 4.00p. The Director now holds 22,055,849 shares. Story provided by...

Prof Sir Duncan Nichol, Director, received in lieu of fees/salary 330,000 shares in the company on the 12th May 2016 at a price of 4.00p. The Director now holds 1,586,912 shares. Story provided...

Julian Cazalet, Non Executive Director, received in lieu of fees/salary 330,000 shares in the company on the 12th May 2016 at a price of 4.00p. The Director now holds 6,456,123 shares. Story...

Nigel Keen, Chairman, received in lieu of fees/salary 833,325 shares in the company on the 12th May 2016 at a price of 4.00p. The Director now holds 22,055,849 shares. Story provided by...

Deltex Medical Group is making good progress towards achieving its key financial and operational goals for 2016, shareholders at the annual general meeting today will be told. Chairman Nigel Keen...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has launched TruFlow, a new, wider beam, single patient disposable probe in the UK and US. The reconfigured probe tip...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring (ODM), posts an operating loss of GBP3.5m for the year to the end of December, up from GBP3.0m in 2014. Revenues were flat...

Story provided by StockMarketWire.com

Deltex Medical Group , the global leader in oesophageal Doppler monitoring, has added two new hospital accounts to its platform programme in the US. The first new hospital is a prestigious...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has raised GBP516,000 through a placing of 12,900,000 new ordinary shares at 4p per share. The proceeds will be applied...

Story provided by StockMarketWire.com

Deltex Medical Group said that at its AGM today the resolution put forward was duly passed. Application has been made for shares to be issued pursuant to the Placing and Open Offer announced on 3...

Deltex Medical says it enters 2016 with growing traction in the US and other export markets driving overall momentum and reducing its exposure to the challenging UK market. The group says sales in...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, is halfway towards its goal of having 30 US hospitals on its platform programme by mid-2016 after adding two further new...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has added two further new accounts to its platform programme in the US. The first new account is a major teaching...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has announced the online publication of a Big Data study of variation in fluid management during surgery in the US, in a...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has launched its first open access ODM online e-learning courses. The UK version is at...

Story provided by StockMarketWire.com

Deltex Medical Group posts an operating loss of £2.1m for the six months to the end of June - up from £1.5m last time. Consumable revenues were flat at £2,530,000. ODM probe revenues were...

Story provided by StockMarketWire.com

Deltex Medical Group, the global leader in oesophageal Doppler monitoring, has added a further new account to its platform programme in the US. The account is a major hospital in the Mid-West and...

Story provided by StockMarketWire.com

The US Food and Drug Administration has approved the release of Deltex Medical's paediatric probes for use with its CardioQ-ODM+ monitors. This dedicated paediatric probe is for use on children...

Story provided by StockMarketWire.com

Deltex Medical Group - a global leader in oesophageal Doppler monitoring - reports strong growth in US and other export markets in the first half but the UK market remains weak. The group also...

Story provided by StockMarketWire.com

Deltex Medical Group has been awarded its first grant by Innovate UK, the UK's innovation agency, to support the funding of the company's research and development programme. The grant covers 35%...

Story provided by StockMarketWire.com

Deltex Medical Group has granted 1,250,000 share options to chief executive Ewan Phillips under the company's 2011 executive share option scheme. The options - which are subject to certain...